Inve India ▾

Asarfi Hospital share price & results

ASARFI HOSPITAL LIMITED· Healthcare

Results to
Jun 2026
Latest analysed call
Q4 FY26
Ownership as of
Sept 2026

Eastern India hospital operator running a Super-Specialty hospital and a dedicated cancer institute in the Dhanbad region of Jharkhand.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue47.3 ₹ crore+32.8% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin19.9 %+0.2 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit4.3 ₹ crore+33.4% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity19.90 %+4.5 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin-0.05 %+12.0 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)36.59 %−10.9 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

1 of 4 judged targets kept · 9 open · verdicts reflect calls analysed to Q4 FY26.

ASARFI HOSPITAL LIMITED management guidance track record on Inve: 13 targets tracked across analysed earnings calls (1 achieved, 3 missed, 9 open).

TargetOriginal wordingSaidLatest callVerdict
Total RevenueRs. 160 crores for FY26
Call transcript, Q2 FY26 · 19 Nov 2025		Q2 FY26Q4 FY26:Achieved. FY26 consolidated revenue was INR 173.5 crores, exceeding the target.
Call transcript, Q4 FY26 · 27 May 2026		Achieved
Cancer Hospital ARPOBRs. 45,000
Call transcript, Q4 FY25 · 12 May 2025		Q4 FY25Q4 FY26:This specific metric was not mentioned in the Q4 FY26 call. Only a blended ARPOB of Rs. 23,000 was provided.
Call transcript, Q4 FY26 · 27 May 2026		Ghosted
Total Bed Capacity500 beds by FY27
Call transcript, Q4 FY25 · 12 May 2025		Q4 FY25Q4 FY26:Timeline pushed. New target is '500 plus beds' as part of 'Vision 2028 roadmap'.
Call transcript, Q4 FY26 · 27 May 2026		Delayed

Source: Inve Guidance Tracker for ASARFI HOSPITAL LIMITED · to Q4 FY26

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

3 of ASARFI HOSPITAL LIMITED's 13 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 10 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹165 −2.77% · −₹4.7

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance +9.5% 1Y

₹150₹200₹250Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 19 Nov 2025Q4 FY26 — 27 May 2026

1Y: ₹150.65 on 24 Oct 2025 → ₹165. High ₹252.8 (8 May 2026), low ₹143 (7 Nov 2025).

Previous close
₹169.7
Market cap
₹384 Cr
52-week range
₹143 – ₹252.8
One year
+4.00%
Price to earnings (TTM to Jun 2026)
21.56×
Return on equity (TTM to Jun 2026)
19.90%

Overview

Symbol
NSE:ASARFI
Exchange
NSE
Currency
INR

What ASARFI HOSPITAL LIMITED does

Based on the company's own presentations, annual report and earnings calls.

Asarfi Hospital Limited operates two hospitals in the Dhanbad region of Jharkhand: a Super-Specialty Hospital offering cardiology, neurosciences, general medicine, orthopaedics, obstetrics & gynaecology, general surgery and other specialties with ICU/NICU/SICU, CCU, emergency and a cardiac unit; and the Asarfi Cancer Institute, a dedicated comprehensive cancer-care hospital offering medical, surgical and radiation oncology with day-care chemotherapy. It earns revenue from in-patient (IPD) and out-patient (OPD) treatment, diagnostics and surgeries, and is empanelled with government schemes (Govt of Jharkhand's MGBUY, East Central Railway, Coal India Limited) and TPAs for cashless healthcare.

Segments

  • Super-Specialty Hospital
  • Cancer Hospital (Asarfi Cancer Institute)
Hospital units
2 (Super-Specialty Hospital + Asarfi Cancer Institute), Dhanbad, Jharkhand
Total bed capacity
350 (297 effective beds)
Super-Specialty Hospital beds
285
Cancer Hospital beds
65
Doctors
66 full-time + 15+ visiting (80+ total)
Nursing & support staff
500
Founded 2005Headquarters Dhanbad, Jharkhand, India Company website

How the price took the results

close before → close after

Q4 FY26
+1.8%
27 May
Q2 FY26
+4.4%
19 Nov

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for ASARFI HOSPITAL LIMITED

Free account: one company. Everything above stays public.

Write why you follow ASARFI HOSPITAL LIMITED and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Healthcare companies

All Healthcare companies → · Healthcare earnings growth →

Learn to analyse ASARFI HOSPITAL LIMITED

Guides on how to read this kind of business and the numbers that matter.